Programma finale completo - SIF - Università degli Studi di Torino

275. Novel G-CSF mutant for conjugation
Salis Barbara, Caboi F., Pitzalis S., Maullu C., Sergi M., Sollai L., Taylor G.
Bio-Ker s.r.l. c/o Scientific and technologic Park of Sardinia Polaris, Loc. Piscinamanna Pula
(Ca)
276. New long lasting PEGylated-hGH
Selis Fabio*, Scaramazza S.*, Contis M.*, Pasut G. + , Veronese F. + , Schrepfer R.*
*Bioker S.r.l. c\o Polaris-Loc Piscinamanna, Pula (CA). + Università degli Studi di Padova,
Dipartimento di Scienze Farmaceutiche
277. Silica Microparticles for the controlled release of human growth hormone
Sergi Mauro*, Morpurgo M. + , Selis F.*, Parisi L. + , Concas D.*, Marongiu C.*, Schrepfer R.*,
Tonon G.*
* Bioker S.r.l. c\o Polaris-Loc Piscinamanna, Pula (CA)
+ Università degli Studi di Padova, Dipartimento di Scienze Farmaceutiche
278. Inhibition of NF-kB activation by decoy ODN released from liposomes in activated
macrophages
De Stefano Daniela 1 , Maiuri M.C 1 ., Simeon V. 1 , De Rosa G. 2 , LaGuardia V. 2 , Carnuccio R. 1
1 Department of Experimental Pharmacology; 2 Department of Pharmaceutical Sciences;
University of Naples “Federico II”, Via D. Montesano n 49, 80131 Naples, Italy
279. Osteogenic differentiation of human adipose-derived stem cells (hASC)
De Girolamo L. 1;2 , Sartori M. 1 , Bastoni S. 3 , Brini A.T. 1
1 Medical Pharmacology Department, Faculty of Medicine, University of Milan.
2 IRCCS Galeazzi Orthopedic Institute, Milan. 3 Orthopedic and Traumatological Institute,
Faculty of Medicine, University of Milan
111
280. In vitro effects of anti-inflammatory drugs incorporated in solid lipid nanoparticles
on human peripheral mononuclear blood cells from IBD patients
Serpe Loredana 1 , Canaparo R. 2 , Daperno M. 3 , Eandi M. 1 , Gasco M.R. 4 , Zara G.P. 1
1 Department of Anatomy, Pharmacology and Forensic Medicine, University of Torino, Torino,
2 Department of Clinical Pathophysiology, University of Torino, Torino, 3 Department of
Gastroenterology, Mauriziano Hospital, Torino, 4 Nanovector s.r.l, Torino
281. PEGylation of Recombinant Human Granulocyte Colony-Stimulating Factor (r-h-G-
CSF) produced in Escherichia coli: a new drug to overcome neutropenia
Bonatesta Rosa Rita*, Caboi F.*, Sergi M.*, Sollai L.*, Onali P. + , Schrepfer R.* Tonon G.*
*Bioker S.r.l. c\o Polaris-Loc Piscinamanna, Pula (CA). + Università degli Studi di Cagliari,
Dipartimento di Neuroscienze
282. EMEA and emerging therapies and technologies: activity of the Innovation Task
Force
De Lisa Roberto, Ranzani D., Brassart L., Moulon I., Papaluca Amati M.
EMEA European Medicines’ Agency
Appropriatezza della prescrizione dei farmaci
Poster 283
283. Indipendent drug information and prescibing appropriateness: a chance for health
professionals and patients
Luppino Maria R. 1,3 , Alacqua M. 1,3 , Catania M.A. 1,3 , Fava G. 1,3 , Gentile M. 1,3 , Oteri A. 1,3 ,
Polimeni G. 1,2,3 , Russo A. 1,3 , Aliferopulos H. 3 , Genovese R. 3 , Sgroi C. 3 , Silvestro A. 3 , Zangla
A. 3 , Caputi A. P. 1,2,3
1 University of Messina -
2 IRCSS “Bonino-Pulejo”, Messina -
3 Messina Provincial Drug
Information Center
pag_dx.indd 1 30/05/2007 4.59.24